 | • レポートコード：MRC308GR11359 • 出版社/出版日：GlobalInfoResearch / 2023年8月14日 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の抗勃起不全（ED）治療薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の抗勃起不全（ED）治療薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 抗勃起不全（ED）治療薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
抗勃起不全（ED）治療薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・シルデナフィル（バイアグラ）、バルデナフィル（レビトラ、スタキシン）、タダラフィル（シアリス）、アバナフィル（ステンドラ）、ウデナフィル（ザイデナ）、その他
用途別セグメント
・病院、小売薬局、クリニック、オンライン薬局
主要な市場プレーヤー
・Vivus, Inc.、Lilly ICOS LLC、Pfizer、Bayer、Hims、Menarini Group、Lupin、Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd、General Factory、CSBio、Dong-A ST、Metuchen Pharma、Seoul Pharma、Teva Pharma、S.K. Chemicals
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、抗勃起不全（ED）治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗勃起不全（ED）治療薬メーカーの企業概要、2019年～2022年までの抗勃起不全（ED）治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗勃起不全（ED）治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別抗勃起不全（ED）治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの抗勃起不全（ED）治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での抗勃起不全（ED）治療薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および抗勃起不全（ED）治療薬の産業チェーンを掲載しています。
・第14、15章では、抗勃起不全（ED）治療薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 抗勃起不全（ED）治療薬の概要
– 種類別分析（2018年vs2022年vs2029年）：シルデナフィル（バイアグラ）、バルデナフィル（レビトラ、スタキシン）、タダラフィル（シアリス）、アバナフィル（ステンドラ）、ウデナフィル（ザイデナ）、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、小売薬局、クリニック、オンライン薬局
– 世界の抗勃起不全（ED）治療薬市場規模・予測
– 世界の抗勃起不全（ED）治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Vivus, Inc.、Lilly ICOS LLC、Pfizer、Bayer、Hims、Menarini Group、Lupin、Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd、General Factory、CSBio、Dong-A ST、Metuchen Pharma、Seoul Pharma、Teva Pharma、S.K. Chemicals
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：シルデナフィル（バイアグラ）、バルデナフィル（レビトラ、スタキシン）、タダラフィル（シアリス）、アバナフィル（ステンドラ）、ウデナフィル（ザイデナ）、その他
・用途別分析2018年-2029年：病院、小売薬局、クリニック、オンライン薬局
・抗勃起不全（ED）治療薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗勃起不全（ED）治療薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗勃起不全（ED）治療薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗勃起不全（ED）治療薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・抗勃起不全（ED）治療薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Anti-erectile Dysfunction (ED) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Sildenafil (Viagra)
1.3.3 Vardenafil (Levitra, Staxyn)
1.3.4 Tadalafil (Cialis)
1.3.5 Avanafil (Stendra)
1.3.6 Udenafil (Zydena)
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Clinic
1.4.5 Online Pharmacy
1.5 Global Anti-erectile Dysfunction (ED) Drugs Market Size & Forecast
1.5.1 Global Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity (2018-2029)
1.5.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Vivus, Inc.
2.1.1 Vivus, Inc. Details
2.1.2 Vivus, Inc. Major Business
2.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product and Services
2.1.4 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Vivus, Inc. Recent Developments/Updates
2.2 Lilly ICOS LLC
2.2.1 Lilly ICOS LLC Details
2.2.2 Lilly ICOS LLC Major Business
2.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product and Services
2.2.4 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Lilly ICOS LLC Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Product and Services
2.3.4 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Product and Services
2.4.4 Bayer Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Recent Developments/Updates
2.5 Hims
2.5.1 Hims Details
2.5.2 Hims Major Business
2.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Product and Services
2.5.4 Hims Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hims Recent Developments/Updates
2.6 Menarini Group
2.6.1 Menarini Group Details
2.6.2 Menarini Group Major Business
2.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Product and Services
2.6.4 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Menarini Group Recent Developments/Updates
2.7 Lupin
2.7.1 Lupin Details
2.7.2 Lupin Major Business
2.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Product and Services
2.7.4 Lupin Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lupin Recent Developments/Updates
2.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
2.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Details
2.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Major Business
2.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product and Services
2.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments/Updates
2.9 General Factory
2.9.1 General Factory Details
2.9.2 General Factory Major Business
2.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Product and Services
2.9.4 General Factory Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 General Factory Recent Developments/Updates
2.10 CSBio
2.10.1 CSBio Details
2.10.2 CSBio Major Business
2.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Product and Services
2.10.4 CSBio Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CSBio Recent Developments/Updates
2.11 Dong-A ST
2.11.1 Dong-A ST Details
2.11.2 Dong-A ST Major Business
2.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product and Services
2.11.4 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Dong-A ST Recent Developments/Updates
2.12 Metuchen Pharma
2.12.1 Metuchen Pharma Details
2.12.2 Metuchen Pharma Major Business
2.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
2.12.4 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Metuchen Pharma Recent Developments/Updates
2.13 Seoul Pharma
2.13.1 Seoul Pharma Details
2.13.2 Seoul Pharma Major Business
2.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
2.13.4 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Seoul Pharma Recent Developments/Updates
2.14 Teva Pharma
2.14.1 Teva Pharma Details
2.14.2 Teva Pharma Major Business
2.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
2.14.4 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Teva Pharma Recent Developments/Updates
2.15 S.K. Chemicals
2.15.1 S.K. Chemicals Details
2.15.2 S.K. Chemicals Major Business
2.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product and Services
2.15.4 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 S.K. Chemicals Recent Developments/Updates
3 Competitive Environment: Anti-erectile Dysfunction (ED) Drugs by Manufacturer
3.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-erectile Dysfunction (ED) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-erectile Dysfunction (ED) Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-erectile Dysfunction (ED) Drugs Manufacturer Market Share in 2022
3.5 Anti-erectile Dysfunction (ED) Drugs Market: Overall Company Footprint Analysis
3.5.1 Anti-erectile Dysfunction (ED) Drugs Market: Region Footprint
3.5.2 Anti-erectile Dysfunction (ED) Drugs Market: Company Product Type Footprint
3.5.3 Anti-erectile Dysfunction (ED) Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-erectile Dysfunction (ED) Drugs Market Size by Region
4.1.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2018-2029)
4.2 North America Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
4.3 Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
4.5 South America Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
5.2 Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type (2018-2029)
5.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
6.2 Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application (2018-2029)
6.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
7.2 North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
7.3 North America Anti-erectile Dysfunction (ED) Drugs Market Size by Country
7.3.1 North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Anti-erectile Dysfunction (ED) Drugs Market Size by Country
8.3.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
10.2 South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
10.3 South America Anti-erectile Dysfunction (ED) Drugs Market Size by Country
10.3.1 South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-erectile Dysfunction (ED) Drugs Market Drivers
12.2 Anti-erectile Dysfunction (ED) Drugs Market Restraints
12.3 Anti-erectile Dysfunction (ED) Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-erectile Dysfunction (ED) Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-erectile Dysfunction (ED) Drugs
13.3 Anti-erectile Dysfunction (ED) Drugs Production Process
13.4 Anti-erectile Dysfunction (ED) Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-erectile Dysfunction (ED) Drugs Typical Distributors
14.3 Anti-erectile Dysfunction (ED) Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Vivus, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Vivus, Inc. Major Business
Table 5. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 6. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Vivus, Inc. Recent Developments/Updates
Table 8. Lilly ICOS LLC Basic Information, Manufacturing Base and Competitors
Table 9. Lilly ICOS LLC Major Business
Table 10. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 11. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Lilly ICOS LLC Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 16. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 21. Bayer Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Recent Developments/Updates
Table 23. Hims Basic Information, Manufacturing Base and Competitors
Table 24. Hims Major Business
Table 25. Hims Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 26. Hims Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hims Recent Developments/Updates
Table 28. Menarini Group Basic Information, Manufacturing Base and Competitors
Table 29. Menarini Group Major Business
Table 30. Menarini Group Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 31. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Menarini Group Recent Developments/Updates
Table 33. Lupin Basic Information, Manufacturing Base and Competitors
Table 34. Lupin Major Business
Table 35. Lupin Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 36. Lupin Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lupin Recent Developments/Updates
Table 38. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Major Business
Table 40. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 41. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments/Updates
Table 43. General Factory Basic Information, Manufacturing Base and Competitors
Table 44. General Factory Major Business
Table 45. General Factory Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 46. General Factory Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. General Factory Recent Developments/Updates
Table 48. CSBio Basic Information, Manufacturing Base and Competitors
Table 49. CSBio Major Business
Table 50. CSBio Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 51. CSBio Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. CSBio Recent Developments/Updates
Table 53. Dong-A ST Basic Information, Manufacturing Base and Competitors
Table 54. Dong-A ST Major Business
Table 55. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 56. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Dong-A ST Recent Developments/Updates
Table 58. Metuchen Pharma Basic Information, Manufacturing Base and Competitors
Table 59. Metuchen Pharma Major Business
Table 60. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 61. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Metuchen Pharma Recent Developments/Updates
Table 63. Seoul Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Seoul Pharma Major Business
Table 65. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 66. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Seoul Pharma Recent Developments/Updates
Table 68. Teva Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Teva Pharma Major Business
Table 70. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 71. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Teva Pharma Recent Developments/Updates
Table 73. S.K. Chemicals Basic Information, Manufacturing Base and Competitors
Table 74. S.K. Chemicals Major Business
Table 75. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 76. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. S.K. Chemicals Recent Developments/Updates
Table 78. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Anti-erectile Dysfunction (ED) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Anti-erectile Dysfunction (ED) Drugs Production Site of Key Manufacturer
Table 83. Anti-erectile Dysfunction (ED) Drugs Market: Company Product Type Footprint
Table 84. Anti-erectile Dysfunction (ED) Drugs Market: Company Product Application Footprint
Table 85. Anti-erectile Dysfunction (ED) Drugs New Market Entrants and Barriers to Market Entry
Table 86. Anti-erectile Dysfunction (ED) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Anti-erectile Dysfunction (ED) Drugs Raw Material
Table 146. Key Manufacturers of Anti-erectile Dysfunction (ED) Drugs Raw Materials
Table 147. Anti-erectile Dysfunction (ED) Drugs Typical Distributors
Table 148. Anti-erectile Dysfunction (ED) Drugs Typical Customers
List of Figures
Figure 1. Anti-erectile Dysfunction (ED) Drugs Picture
Figure 2. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Type in 2022
Figure 4. Sildenafil (Viagra) Examples
Figure 5. Vardenafil (Levitra, Staxyn) Examples
Figure 6. Tadalafil (Cialis) Examples
Figure 7. Avanafil (Stendra) Examples
Figure 8. Udenafil (Zydena) Examples
Figure 9. Others Examples
Figure 10. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Application in 2022
Figure 12. Hospital Examples
Figure 13. Retail Pharmacy Examples
Figure 14. Clinic Examples
Figure 15. Online Pharmacy Examples
Figure 16. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity (2018-2029) & (K Units)
Figure 19. Global Anti-erectile Dysfunction (ED) Drugs Average Price (2018-2029) & (US$/Unit)
Figure 20. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of Anti-erectile Dysfunction (ED) Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 Anti-erectile Dysfunction (ED) Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 Anti-erectile Dysfunction (ED) Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 27. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 32. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 35. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 37. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 38. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. United States Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 58. China Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Anti-erectile Dysfunction (ED) Drugs Market Drivers
Figure 79. Anti-erectile Dysfunction (ED) Drugs Market Restraints
Figure 80. Anti-erectile Dysfunction (ED) Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Anti-erectile Dysfunction (ED) Drugs in 2022
Figure 83. Manufacturing Process Analysis of Anti-erectile Dysfunction (ED) Drugs
Figure 84. Anti-erectile Dysfunction (ED) Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source